Kaida BioPharma is advancing targeted anti-cancer hormonal therapies to address the root cause of cancers affecting women.

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

These microbes produce metabolites that might be used to treat bacterial infections, cancer, type 2 diabetes, and much more.

With several surfactants to choose from, the biopharma industry is still working to identify the most effective, environmentally friendly alternatives to the surfactant Triton X-100 (TX-100). The EU ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

Method reveals unexpected behavior in molecular crowding during cell state transitions and suggests density as a biomarker for functional precision medicine.

Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...

Beyond the heart, the study hints that other transplantable organs could benefit from improved cold storage methods using a simple diuretic.

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.